154 related articles for article (PubMed ID: 87679)
1. Improvement of chronic congestive heart-failure by oral captopril.
Turini GA; Brunner HR; Gribic M; Waeber B; Gavras H
Lancet; 1979 Jun; 1(8128):1213-5. PubMed ID: 87679
[TBL] [Abstract][Full Text] [Related]
2. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
Levine TB; Franciosa JA; Cohn JN
Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102
[No Abstract] [Full Text] [Related]
3. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.
Davis R; Ribner HS; Keung E; Sonnenblick EH; LeJemtel TH
N Engl J Med; 1979 Jul; 301(3):117-21. PubMed ID: 221810
[TBL] [Abstract][Full Text] [Related]
5. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
Creager MA; Faxon DP; Weiner DA; Ryan TJ
Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
[TBL] [Abstract][Full Text] [Related]
7. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
[TBL] [Abstract][Full Text] [Related]
8. The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
Kubo S; Nishioka A; Nishimura H; Sonotani N; Takatsu T
Jpn Circ J; 1980 Jun; 44(6):427-37. PubMed ID: 6995635
[No Abstract] [Full Text] [Related]
9. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
Awan NA; Evenson MK; Needham KE; Win A; Mason DT
Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
[TBL] [Abstract][Full Text] [Related]
10. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
11. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
12. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
[TBL] [Abstract][Full Text] [Related]
13. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T
Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
Packer M; Medina N; Yushak M
Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
Packer M; Lee WH; Medina N; Yushak M
J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397
[TBL] [Abstract][Full Text] [Related]
16. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
[TBL] [Abstract][Full Text] [Related]
17. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
18. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
[TBL] [Abstract][Full Text] [Related]
19. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
[TBL] [Abstract][Full Text] [Related]
20. Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.
Riegger GA; Liebau G; Holzschuh M; Witkowski D; Steilner H; Kochsiek K
Am J Cardiol; 1984 Feb; 53(4):614-8. PubMed ID: 6320625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
